Hosted on MSN1mon
Durham startup Tune Therapeutics raises $175 million as it starts novel gene therapy trialLaunched from a Duke University lab four years ago, the biotech startup Tune Therapeutics announced ... offices in Seattle and at the downtown Durham ID building. Series A and B are the two ...
Hosted on MSN1mon
Fast-moving Durham startup Tune Therapeutics works to turn off genes that cause diseasesLaunched from a Duke University lab four years ago, the biotech startup Tune Therapeutics announced ... offices in Seattle and at the downtown Durham ID building. Series A and B are the two ...
Leading epigenome company Tune Therapeutics is proud to announce that veteran drug-development executive John McHutchison AO, ...
New leadership at Seattle-area companies including Starbucks, Avanade, Tune Therapeutics, Umoja Biopharma, Siteimprove and ...
Express Scripts,… Read More Tune Therapeutics, a biotech company with headquarters in Seattle and Durham, N.C., raised $175 million in one of the largest funding rounds for a Seattle-area ...
Leading epigenome editing company Tune Therapeutics (Tune) today announced the completion of over $175M in financing led by New Enterprise Associates, Yosemite, Regeneron Ventures and Hevolution ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback